je.st
news
Tag: regulatory
Press release distribution, EDGAR filing, XBRL, regulatory filings
2014-07-02 04:24:06| Chemicals - Topix.net
Re-mastered album reissue out October 7th, 2014 . Unique one-off live performance at London's Royal Festival Hall )--In January '94, Rick Smith, Darren Emerson & Karl Hyde released their debut album - Dubnobasswithmyheadman - on UK independent label Junior Boy's Own.
Tags: press
release
distribution
press release
Press release distribution, EDGAR filing, XBRL, regulatory filings
2014-07-01 11:08:15| Appliances - Topix.net
These shares were registered i... )--Focusing on the growing impact of the Video On Demand platform on the media landscape, Nielsen's Q1 2014 Cross-Platform Report reflects that VOD users of all ethnic... )--The ADT Corporation will release financial results for its third fiscal quarter 2014 before trading begins on Wednesday, July 30, 2014, and ... (more)
Tags: press
release
distribution
press release
Press release distribution, EDGAR filing, XBRL, regulatory filings
2014-06-30 18:07:28| Jewelry - Topix.net
He w... )--Michelle Trindade has been promoted to vice president of GEICO's competitive advantage leadership group located in Chevy Chase, Maryland.
Tags: press
release
distribution
press release
Press release distribution, EDGAR filing, XBRL, regulatory filings
2014-06-30 15:30:55| Waste Management - Topix.net
Following... )--For the second consecutive year, the Waste Management Phoenix Open has diverted 100 percent of waste away from landfills amid this year's record attendance of 56... )--AMLIN plc TOTAL VOTING RIGHTS AND SHARE CAPITAL In accordance with the FCA's Disclosure and Transparency Rules, Amlin plc advises the market that as at 30 June 20...
Tags: press
release
distribution
press release
Mercks Investigational Anti-PD-1 Antibody, Pembrolizumab, Under Regulatory Review in Europe for the Treatment of Advanced Melanoma
2014-06-30 12:00:00| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the European Medicines Agency (EMA) has accepted for review a Marketing Authorization Application (MAA) for pembrolizumab (MK-3475), the companys investigational anti-PD-1 antibody, for the treatment of advanced melanoma. If approved by the European Commission (EC), pembrolizumab has the potential to be the first anti-PD-1 therapy in Europe. Language: English Contact: Media:Steve Cragle, 973-432-4781Claire Mulhear, 908-423-7425orInvestors:Joseph Romanelli, 908-423-5185Justin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: advanced
review
europe
treatment
Sites : [376] [377] [378] [379] [380] [381] [382] [383] [384] [385] [386] [387] [388] [389] [390] [391] [392] [393] [394] [395] next »